releases: https://walden.house.gov/media-center/press-releases/greg-walden-statement-trump-administrations-commitment-lowering
Data license: MIT · Data source: dwillis/congress-press
This data as json
| url | title | date | year | month | party | chamber | state | member_name | bioguide_id | domain | scraper | source | date_source | text | has_text | collected_at | updated_at |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| https://walden.house.gov/media-center/press-releases/greg-walden-statement-trump-administrations-commitment-lowering | Greg Walden Statement on Trump Administration's Commitment to Lowering Prescription Drug Prices | 2019-07-31 | 2019 | 2019-07 | Republican | House | OR | Greg Walden | W000791 | walden.house.gov | legacy | Representative Greg Walden (R-Hood River) released the following statement after the U.S. Department of Health and Human Services (HHS) and Food and Drug Administration (FDA) announced their new action plan for the safe importation of certain prescription drugs: "When it comes to lowering drug prices, I've never seen a president more engaged than President Trump. I appreciate the Administration's continued focus on lowering drug prices -- from the White House, to Secretary Alex Azar, to Acting FDA Commissioner, Dr. Ned Sharpless.The U.S. drug supply chain is the gold standard and the FDA is charged with ensuring drug safety to protect the public health. Ilook forward to continuing to work with HHS and FDA as we explore these paths to lower drug prices for American consumers, while ensuring Americans can remain confident that the drugs they take are safe and effective," said Walden. | 1 | 2026-03-30T12:14:52Z | 2026-03-30T12:14:52Z |